LAVA Therapeutics NV
LVTX1.415USD
-0.005-0.35%
交易中 （美東）報價延遲15分鐘
37.22M總市值
虧損本益比TTM
關於 LAVA Therapeutics NV 公司
LAVA Therapeutics NV 前身爲 Lava Therapeutics BV，是一家總部位於荷蘭的生物技術研發服務提供商。該公司專注於開發下一代 Vdelta T 細胞結合雙特異性抗體來對抗癌症。
公司簡介
公司代碼LVTX
公司名稱LAVA Therapeutics NV
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
員工數量34
證券類型Ordinary Share
年結日Mar 25
公司地址Yalelaan 60
城市UTRECHT
上市交易所NASDAQ Global Select Consolidated
國家Netherlands
郵編3584 CM
電話31630003035
網址https://www.lavatherapeutics.com/
公司代碼LVTX
上市日期Mar 25, 2021
CEOMr. Stephen A. Hurly
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson
Ms. Karen J. Wilson
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stephen A. Hurly
Mr. Stephen A. Hurly
President, Chief Executive Officer, Management Director
President, Chief Executive Officer, Management Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson
Ms. Karen J. Wilson
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 6月4日 週三
更新時間: 6月4日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
17.44%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.45%
Sanofi SA
7.30%
Other
39.31%
持股股東
持股股東
佔比
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
17.44%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.45%
Sanofi SA
7.30%
Other
39.31%
股東類型
持股股東
佔比
Corporation
32.27%
Venture Capital
17.53%
Investment Advisor
10.83%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
0.42%
Individual Investor
0.42%
Research Firm
0.22%
Other
30.35%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
48
18.32M
69.65%
-2.73M
2025Q1
59
22.25M
84.60%
-1.27M
2024Q4
61
18.80M
71.50%
-11.80K
2024Q3
56
15.93M
60.60%
-3.34M
2024Q2
58
16.07M
61.13%
-4.19M
2024Q1
58
16.06M
61.10%
-4.38M
2023Q4
51
18.10M
68.85%
+283.15K
2023Q3
52
18.00M
68.48%
-418.56K
2023Q2
55
18.03M
68.58%
-1.16M
2023Q1
60
19.21M
73.06%
-886.64K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Cooperatieve Gilde Healthcare IV UA
5.42M
20.61%
--
--
Mar 31, 2025
Versant Ventures
4.59M
17.44%
--
--
Mar 31, 2025
Redmile Group, LLC
2.07M
7.89%
--
--
Mar 31, 2025
BML Capital Management LLC
1.96M
7.45%
+2.50K
+0.13%
Mar 31, 2025
Sanofi SA
1.92M
7.3%
+1.92M
--
Dec 31, 2024
Merck & Co Inc
1.15M
4.37%
--
--
Mar 31, 2025
Bruce & Company, Inc.
521.87K
1.98%
-250.00K
-32.39%
Mar 31, 2025
Zenito Oy
156.83K
0.6%
--
--
Mar 31, 2025
Pathway Financial Advisors, LLC
102.50K
0.39%
--
--
Mar 31, 2025
Powell (Fred M)
65.00K
0.25%
-7.56K
-10.42%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
AltShares Event-Driven ETF
0%
AltShares Event-Driven ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
